{
    "nctId": "NCT05586256",
    "briefTitle": "Ultra-hypofractionated Radiotherapy in Breast Cancer Patients",
    "officialTitle": "Ultra-hypofractionated Adjuvant Radiotherapy After Breast Conserving Surgery in Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Female Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Acute toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients\n* Age \u2265 18 years.\n* Early stage breast cancer treated with breast conserving surgery\n* Whole breast irradiation without regional nodal irradiation\n* Infiltrating carcinomas\n* CDIS\n* Written informed consent\n\nExclusion Criteria:\n\n* Age\\<18 years.\n* Regional nodal radiotherapy.\n* Distant metastases.\n* Previous history of malignancy except basaloid skin tumours and CIN. Previous history of breast cancer is not an exclusion criteria if treated with curative intent and if patient is disease free at least 5 years from diagnosis.\n* Presence of absolute radiotherapy contraindications (pregnancy, inability to maintain the correct treatment position) and relative radiotherapy contraindications (connective tissue diseases including rheumatoid arthritis, scleroderma, systemic lupus erythematosus, dermatomyositis and vasculitis, especially if the disease is in an active phase)\n* Patient's refusal to use data for research purposes.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}